The Archer® FusionPlex® Lymphoma Kit is a targeted next generation sequencing
assay to simultaneously detect and identify fusions, point mutations, and expression levels in 125 genes linked to lymphomas. Using Anchored Multiplex PCR
(AMP™)-based enrichment, fusions can be identified even without prior knowledge of fusion partners or breakpoints.